Logo

Expression Analysis Offers Affymetrix Microarray Genotyping Services

Aug 30, 2004

NEW YORK, Aug. 30 (GenomeWeb News) - Expression Analysis said last week that it has expanded its pharmacogenomics testing services to include genotyping using Affymetrix's Centurion array set and GeneChip Mapping 10K 2.0 arrays.

 

"The Centurion Array set eliminates the need for locus-specific PCR reactions and allows researchers to evaluate over 100,000 DNA polymorphisms using an innovative assay requiring only 500 nanograms of DNA for each sample," Steve McPhail, Expression Analysis' CEO, said in a statement.

 

The GeneChip Mapping 10K 2.0 arrays allow for the measurement of more than 10,000 genotypes in a single experiment and are cost comparable with microsatellite analysis, the company said.

 

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.